All Stories

  1. Targeted therapy for pulmonary alveolar proteinosis: the time is now

    Article • European Respiratory Journal, April 2022, European Respiratory Society (ERS)

    francesco bonella, Francesco Bonella

  2. The Gender-Age-Physiology (GAP) Index enhanced with KL-6 serum level for predicting disease progression in interstitial lung diseases (ILD)

    Article • September 2020, European Respiratory Society (ERS)

    francesco bonella

  3. Consistent effect of nintedanib on reducing FVC decline across interstitial lung diseases (ILDs)

    Article • September 2020, European Respiratory Society (ERS)

    francesco bonella

  4. Serum KL-6 as a biomarker for interstitial lung diseases in a clinical setting: application of a fully automated immunoassay

    Article • September 2019, European Respiratory Society (ERS)

    francesco bonella

  5. Potential clinical utility of MUC5B and TOLLIP single nucleotide polymorphisms (SNP) in in the management of patients with IPF

    Article • September 2019, European Respiratory Society (ERS)

    francesco bonella

  6. Differential diagnosis of granulomatous lung disease: clues and pitfalls

    Article • European Respiratory Review, August 2017, European Respiratory Society (ERS)

    francesco bonella, Francesco Bonella

  7. Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitis

    Article • European Respiratory Journal, November 2016, European Respiratory Society (ERS)

    francesco bonella, Francesco Bonella

  8. European idiopathic pulmonary fibrosis Patient Charter: a missed opportunity

    Article • European Respiratory Journal, June 2016, European Respiratory Society (ERS)

    francesco bonella, Francesco Bonella

  9. Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib

    Article • Drug Design Development and Therapy, December 2015, Dove Medical Press

    francesco bonella, Francesco Bonella

  10. European IPF Patient Charter: unmet needs and a call to action for healthcare policymakers

    Article • European Respiratory Journal, November 2015, European Respiratory Society (ERS)

    francesco bonella, Francesco Bonella

  11. Biomarker discovery in systemic sclerosis: state of the art

    Article • Current Biomarker Findings, July 2015, Dove Medical Press

    francesco bonella

  12. Update on therapeutic management of idiopathic pulmonary fibrosis

    Article • Therapeutics and Clinical Risk Management, March 2015, Taylor & Francis

    Professor Paolo Spagnolo, francesco bonella, Francesco Bonella